Considering that there has been an explosive growth in research on PKM in cancer, we further focus on FSTL3 and confirmed the abnormal expression of FSTL3 in two independent validations set (P < 0.0001, Fig. 5G). The gene discussed is FSTL3; the disease is cancer.